Inactivation of one allele of FT5. by Sophia Bigot (16469992)

Decreased FOXP3 Treg induction in LAG-3 KO T-cells in an <i>in vivo</i> self-tolerance. by Nicholas M. Durham (174371)

Increased biogenesis of ribosomes in the kidneys from rats administered Tl. by Sho Sugahara (11895828)

Average predicted probabilities for top 5 publications & average initial placement rankings, controlling for ability, as a function of Alma mater ranking. by Sergey V. Popov (6719075)

Induction of CXCL8 in THP-1 cells was decreased in response to H37Ra in the presence of CLEC9A blocked. by An-Chieh Cheng (4532641)

Effect of X-irradiation on osteogenic differentiation of hMSCs. by Séverine Cruet-Hennequart (716700)

Knockdown of BgTLR in BS-90 snails decreases haemocyte phagocytic response. by Emmanuel A. Pila (2572768)

EGCG and luteolin do not synergistically reduce WPMY-1 cell proliferation and viability. by Alana L. Gray (637670)

Neutrophil depletion is associated with decreased intracellular cytokine levels and changes in transcription factor mRNA expression related to T helper subsets during the chronic s... by Juan David Puerta-Arias (3187089)

Aging slows theta peak frequency (TPF) and decreases slow wave activity (SWA) at low frequencies (0.5–1.5 Hz). by Mathieu E. Wimmer (498169)

Mass-normalized work per unit distance and recovery over the step as a function of speed and slope while walking uphill. by Arthur H. Dewolf (4537918)

Inclusion of SRRM4-regulated exons is decreased in tumors and cancer cell lines. by Sarah A. Head (6066398)

“…(B) SRRM4 target exons with respect to their average PSI in normal tissues. Red points are exons with PSI decreasing by at least 5% in at least 1 tumor type. …”

Optogenetic stimulation of CA1 astrocytes for 5- or 10-min had no significant effect on cognitive function. by Jae-Hong Kim (124622)

(R)-Albuterol decreases pulmonary inflammation after OVA sensitization and aerosol challenge by Marcela A Ferrada (41716)

“…A) PBS+pump, B) OVA+ pump, C) PBS+(R), D) OVA+(R), E) PBS+(S) and F) OVA+ (S). These pictures are representative of two mice examined in each group. …”

Association between Metabolic Syndrome and Decreased eGFR. by Daqing Hong (768230)

“…</p><p>Association between Metabolic Syndrome and Decreased eGFR.</p>…”

Contains underlying data for Figs 1A, 1F, 1G, 1I, 1J, 2D, 2E, 2G, 2H, 2J, 2K, 2M, 2N, 3A, 3B, 3C, 3D, 3F, 4A, 4B, 4C, 4D, 4E, 5I, 6A, 6B, 6D, 6F, 7B, 7D, and 7F and S1A, S1B, S3A,... by Xiao Chen Shi (8611887)

A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele-0 by Ryan J Haasl (92283)

“…<p><b>Copyright information:</b></p><p>Taken from "A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele"</p><p>http://www.biomedcentral.com/1471-2350/9/37</p><p>BMC Medical Genetics 2008;9():37-37.…”

A luteinizing hormone receptor intronic variant is significantly associated with decreased risk of Alzheimer's disease in males carrying an apolipoprotein E ε4 allele-1 by Ryan J Haasl (92283)

“…For each polymorphism, genotype frequencies are represented in the form of two pie charts, where the left chart represents genotype frequencies among individuals lacking an LQ-insert allele in exon 1 of (lhcgr1) and the right chart represents genotype frequencies among individuals possessing 1 or 2 LQ-insert alleles. …”

Protective effects of 0.2 μM cyclosporine A (CsA) on the sensitivity of mPTP opening under de-energized conditions. by Gonçalo C. Pereira (9022700)

MCP-1-deficiency decreased CD11c-expressing cells via impairing the production of ROS and decreased activation of PLCγ2, Akt, and ERK upon M-CSF stimulation in BMM. by Woon-Ki Kim (447798)

“…<p>BMMs from WT (open bar) and MCP-1-KO mice (oblique-lined bar) were incubated in the presence of M-CSF (30 ng/ml) with U73122 (10 µM), Akt inhibitor IV (0.3 µM), PD098059 (5 µM), DPI (50 nM), NAC (3 mM), or H₂O₂ (300 µM) for 4 d (A). *, <i>P</i><0.05; ***, <i>P</i><0.001 compared with vehicle-treated WT cells. …”